The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Foundation Research Explores Relationship Between RA and Cardiovascular Disease

Foundation Research Explores Relationship Between RA and Cardiovascular Disease

December 1, 2012 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Pennathur
Dr. Pennathur

Subramaniam Pennathur MD, associate professor of medicine at University of Michigan School of Medicine in Ann Arbor, is a nephrologist by training. His research focuses primarily on the complications caused by metabolic diseases, particularly diabetes, but a conversation with a colleague and a grant from the Rheumatology Research Foundation set him on different course—studying why rheumatoid arthritis (RA) patients have an elevated risk of heart disease.

You Might Also Like
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA
  • Cardiovascular Disease Risk High in RA Patients
  • American College of Rheumatology (ACR) Research and Education Foundation Brings Researchers Together in Santa Fe
Explore This Issue
December 2012
Also By This Author
  • Russians Mourn Iconic Rheumatologist

“I got interested in this subject, in part, because one of my colleagues here at the University of Michigan, Dr. Mariana Kaplan, is interested in autoimmune diseases, especially rheumatoid arthritis,” says Dr. Pennathur. “We had a discussion initially about the causes of cardiovascular disease, and she talked about how rheumatoid arthritis markedly increases the risk of cardiovascular disease, and it is not very well known what the factors are. For example, premenopausal women in general are protected from cardiovascular disease. Yet in RA, that protection seems to be lost. We were discussing how best to look at our common interest in cardiovascular disease, and actually apply my expertise in that area to a new area of research, which is rheumatoid arthritis.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After Dr. Pennathur’s discussions with Dr. Kaplan, associate professor of medicine in the rheumatology division at the University of Michigan School of Medicine, the pair started looking at RA patients who were already enrolled in an NIH-funded study where Dr. Kaplan was the principal investigator, and started examining how high-density lipoprotein (HDL), which is associated with protection from cardiovascular disease, is different in RA patients.

“The premise of our proposal was to look at HDL cholesterol and how that is changed in patients with rheumatoid arthritis,” says Dr. Pennathur.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Drs. Pennathur and Kaplan quickly discovered that RA does affect HDL.

“Our first finding was that patients with RA, even without cardiovascular disease, had significantly damaged HDL. That damage occurs through oxidation via an enzyme called myeloperoxidase,” Pennathur explains. “The enzyme is present in white blood cells, so it is present in neutrophils and macrophages. Our hypothesis was that the joint inflammation and the general state of increased inflammation that characterizes RA makes the white blood cells secrete more myeloperoxidase that, in turn, damages HDL. Normally the neutrophil myeloperoxidase is utilized for killing bacteria.

When you have an infection of some sort, the myeloperoxidase actually generates oxidants, which actually kill the bacteria. In this circumstance, it’s damaging circulating HDL, which, in turn, loses its protective effect. Patients with rheumatoid arthritis, even without cardiovascular disease, have this problem.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College, Research Reviews, Rheumatoid Arthritis Tagged With: AC&R, American College of Rheumatology, Cardiovascular disease, patient care, REF, Research, Rheumatoid arthritis, Rheumatology Research FoundationIssue: December 2012

You Might Also Like:
  • Cardiovascular Disease Mortality Risk Remains Higher for Patients with RA
  • Cardiovascular Disease Risk High in RA Patients
  • American College of Rheumatology (ACR) Research and Education Foundation Brings Researchers Together in Santa Fe
  • Cardiovascular Disease in Rheumatoid Arthritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.